Rank: 35
Emma Walmsley
CEO, GlaxoSmithKline
Walmsley has led the U.K.-based drug and vaccine giant since early 2017. In April, GSK announced a collaboration with drugmaker Sanofi to develop a vaccine to combat the coronavirus. The vaccine is already in advanced clinical trials, with wide distribution projected in 2021 if data supports approval, according to a Sanofi news release. “Tackling this virus urgently requires partnerships, a global approach, commitment to access and investment in long-term pandemic preparedness,” Walmsley said.